Alexandria Real Estate Equities Honored as One of America's Most Trustworthy Companies for Fourth Consecutive Year

Alexandria Real Estate Equities Honored for Trustworthiness

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a leader in life science real estate, has been recognized once again by Newsweek as one of the Most Trustworthy Companies in America. This is the fourth consecutive year that Alexandria has achieved this prestigious accolade, ranking as the second most trustworthy company in the real estate and housing category for 2026. This recognition is a testament to Alexandria’s unwavering reputation in the field and its essential role in the life science sector.

The annual list created by Newsweek, in partnership with Statista, is based on thorough research involving an independent survey of 25,000 U.S. residents, yielding over 101,000 evaluations across various trust dimensions: customer, investor, and employee. Additionally, the examination of online sentiment contributes to this esteemed ranking.

Joel S. Marcus, the Executive Chairman and founder of Alexandria, expressed his gratitude for this recognition. He highlighted the company's consistent endeavor to make a positive impact as a mission-driven entity at the forefront of the life sciences industry. As Marcus aptly quoted, 'Excellence is never an accident. It is the result of high intention, sincere effort, and intelligent execution.' This philosophy resonates throughout Alexandria, from its dedicated team to its critical support of tenants, facilitating the innovation that leads to life-saving developments.

Since its inception, Alexandria has played a pivotal role in the biotechnology and pharmaceutical sectors, significantly assisting in the development of nearly half of all FDA approvals since 2013. Their commitment to fostering enduring relationships with prominent life science companies like Eli Lilly, Bristol Myers Squibb, and Novartis underlines their strategic importance in the sector. In 2025, a remarkable 82% of the company’s leasing activity stemmed from existing tenants, showcasing the trust and reliance placed on Alexandria.

The organization is also noted for its development prowess, recently commencing construction on a Biomedical Research Center at the Campus Point Megacampus in San Diego. This 466,598 RSF facility, tenants can expect cutting-edge infrastructure designed for advanced research capabilities and artificial intelligence applications. This underscores the industry's trust in Alexandria and its unique ability to deliver unparalleled real estate opportunities.

Currently, Alexandria operates within clusters termed Megacampus ecosystems, which convey irreplaceable assets located in prime areas, serving as hubs for scientific innovation. These spaces are meticulously designed to enhance collaborations and promote tenant well-being—essentials for attracting and retaining top talent in the highly competitive biomedical field.

As a multi-year recipient of this trustworthiness recognition, Alexandria continues to illustrate its commitment to integrity and societal impact. The company’s vision transcends profit-making; it aims to generate sustainable ecosystems that could significantly enhance human health while reinforcing the communities its employees and tenants inhabit.

About Alexandria Real Estate Equities

Founded in 1994, Alexandria Real Estate Equities, Inc. is recognized as a leader in life science real estate investment, boasting a total market capitalization of $20.75 billion as of December 31, 2025. The company maintains a robust asset base of 35.9 million RSF in North America. Alexandria prides itself on creating high-quality, collaborative environments that foster innovation and streamline operational efficiencies for its tenants. In addition to its real estate endeavors, Alexandria also engages in venture capital investments in transformative life science companies.

For those interested in learning more about Alexandria’s influence and contributions to the life sciences sector, additional information can be found at their official webpage: www.are.com.